Diagnostics company BillionToOne has secured Emergency Use Authorisation (EUA) from the US Food and Drug Administration (FDA) for its SARS-CoV-2 diagnostic test, which is designed to remove the costly and time-consuming step of RNA extraction. Compared with most other molecular assays that depend on RNA extraction and qRT-PCR, the firm’s qSanger-COVID-19 assay makes use of a different set of instruments and chemicals from existing tests, which in turn allows labs to tap a new, unused capacity for the detection of Covid-19 causing SARS-CoV-2.

Swiss company ender diagnostics has announced collaboration with Swiss International Air Lines (SWISS), a subsidiary of Lufthansa, to test all long-haul cabin crew members for SARS-CoV-2. Testing the long-haul crew members of SWISS before departure will help to further boost detection of Covid-19 infection and boost the safety of people travelling.

The Union Health Ministry of India has updated its advisory on testing strategy for Covid-19. It has introduced on-demand testing without the need for a prescription. However, it has allowed the state health authorities to alter the modules according to their requirements.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData